Effect of heparin, epsilon-aminocaproic acid and coumarin on tumour growth and spontaneous metastasis formation.
D000614:Aminocaproates / Q000627:therapeutic use*; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D003374:Coumarins / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000517:prevention & control; D008748:Methylcholanthrene; D051379:Mice; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009368:Neoplasm Transplantation; D012208:Rhabdomyosarcoma / Q000139:chemically induced / Q000517:prevention & control*; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000517:prevention & control* / Q000601:surgery; D013623:Tail
D000614:Aminocaproates; D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D003374:Coumarins; D008748:Methylcholanthrene; D006493:Heparin